Re: Latest on the Corona Virus
Chinese COVID-19 vaccine effectiveness 'not high,' government exploring options: officials
CDC director Gao Fu urged China to explore mRNA treatments
China's coronavirus vaccines may not provide the appropriate protection, with the government exploring options to try and boost efficacy as additional vaccines enter clinical trials.
In a rare admission from a normally tight-lipped government, Chinese health officials admitted that the vaccines "don't have very high protective rates."
"It's now under formal consideration whether we should use different vaccines from different technical lines for the immunization process," China Centers for Disease Control director Gao Fu said at a conference Saturday.
Drug companies Sinopharm and Sinovac were the leading producers for China's vaccine efforts, with their products exported to 22 countries including Mexico, Turkey, Indonesia, Brazil and Turkey.
Sinopharm initially reported a 79% efficacy rate, but did not release any trial data for the vaccines.
Meanwhile, foreign trials for the Sinovac vaccine have found a wide range of efficacy, with Brazil reporting 50% efficacy for and Turkey reporting over 80% efficacy.
Health experts say the Chinese vaccines are unlikely to be sold to the United States or Western Europe due to the complexity of the approval process.
Chinese COVID-19 vaccine effectiveness 'not high,' government exploring options: officials
CDC director Gao Fu urged China to explore mRNA treatments
China's coronavirus vaccines may not provide the appropriate protection, with the government exploring options to try and boost efficacy as additional vaccines enter clinical trials.
In a rare admission from a normally tight-lipped government, Chinese health officials admitted that the vaccines "don't have very high protective rates."
"It's now under formal consideration whether we should use different vaccines from different technical lines for the immunization process," China Centers for Disease Control director Gao Fu said at a conference Saturday.
Drug companies Sinopharm and Sinovac were the leading producers for China's vaccine efforts, with their products exported to 22 countries including Mexico, Turkey, Indonesia, Brazil and Turkey.
Sinopharm initially reported a 79% efficacy rate, but did not release any trial data for the vaccines.
Meanwhile, foreign trials for the Sinovac vaccine have found a wide range of efficacy, with Brazil reporting 50% efficacy for and Turkey reporting over 80% efficacy.
Health experts say the Chinese vaccines are unlikely to be sold to the United States or Western Europe due to the complexity of the approval process.
Comment